What is the price target for CELL stock?
7 analysts have analysed CELL.MI and the average price target is 3.98 EUR. This implies a price increase of 74.47% is expected in the next year compared to the current price of 2.28.
CELLULARLINE SPA (CELL.MI) Forecast, Price Target & Analyst Ratings
BIT:CELL • IT0005244618
Current stock price
2.28 EUR
+0.01 (+0.44%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CELLULARLINE SPA (CELL.MI).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
€3.98
Upside
+ 74.47%
From current price of €2.28 to mean target of €3.98, Based on 7 analyst forecasts
Low
€3.94
Median
€3.98
High
€4.10
Price Target Revisions
1 Month
-4.88%
3 Months
-4.88%
Price Target Summary
7 Wall Street analysts provided a forecast for the next 12 months for CELL.MI. The average price target is 3.98 EUR. This implies a price increase of 74.47% is expected in the next year compared to the current price of 2.28.
The average price target has been revised downward by 4.88% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
82.86%
CELL.MI was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about CELL.MI.
In the previous month the buy percentage consensus was at a similar level.
CELL.MI was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 5, 2026
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates 2026 - 2027
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 158.648M 15.26% | 164.263M 3.54% | 156.643M -4.64% | 161.16M 2.88% | 165.24M 2.53% | |
| EBITDA YoY % growth | 18.47M -78.85% | 21.79M 17.98% | 60.285M 176.66% | 21.757M -63.91% | 22.307M 2.53% | |
| EBIT YoY % growth | 5.065M 776.23% | 8.066M 59.25% | 4.392M -45.55% | 16.759M 281.58% | N/A | |
| Operating Margin | 3.19% | 4.91% | 2.80% | 10.40% | N/A | |
| EPS YoY % growth | N/A -25.20% | N/A 4.17% | N/A -17.50% | 0.34 | 0.36 6.06% |
All data in EUR
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in EUR
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
CELLULARLINE SPA / CELL.MI Forecast FAQ
What is the next earnings date for CELL stock?
CELLULARLINE SPA (CELL.MI) will report earnings on 2026-05-05.
Can you provide the analyst count for CELLULARLINE SPA stock?
The number of analysts covering CELLULARLINE SPA (CELL.MI) is 7.